A method for measuring the rate of total daily cholesterol synthesis in man has been developed through isotope kinetic studies of squalene biosynthesis after intravenous administration of ['4Cjnievalonic Plasma squalene measurements were made as described elsewhere (5), using 3 ml of plasma for each determination.
The measurement of cholesterol synthesis rates in intact animals and man is currently carried out in two ways: by the sterol balance methods developed in this laboratory (1) and by studies of cholesterol kinetics using compartmental analysis (2) or input-output analysis (3) after administration of radioactive cholesterol. Both methods demand the existence of the metabolic steady state, in which there is neither net gain nor loss of total body cholesterol. The present report describes a new approach to the measurement of cholesterol synthesis rates, in which squalene synthesis is measured and equated to that of cholesterol.
MATERIALS AND METHODS
Materials. DL-[2-14C]Mevalonolactone (17.5 lesterol (40 mCi/mmol) was purchased from New England Nuclear, Boston, Mass. Preparation of Radioisotopic Materials for Intravenous Infusion. The purity of the two radioactive mevalonolactones was routinely checked by thin-layer chromatography (benzene:acetone = 1:1) (4) (>98% pure). These lactones, stored in benzene solution, were dried under N2 and were converted to the free acids by mixing with 8 ml of sterile physiological Na-bicarbonate by ultrasonication (5 min Plasma squalene measurements were made as described elsewhere (5), using 3 ml of plasma for each determination. 4612 Radioactivity measurements were made on separate aliquots of the same extract subjected to gas-liquid chromatography by methods described (6) . Since the radioactivity levels are low, even at the peak of the squalene curve (100-60 dpm above background), it is important to carry out quench corrections and counting efficiencies by addition of an internal standard to each sample, discarding counts that are less than three times background (usually 7 hr after MVA dosage).
Cholesterol [4] To convert squalene synthesis to cholesterol synthesis, a correction must be made for the difference in their molecular weights, i.e., multiplication of the squalene synthesis rate (mg/day) by 0.942 (= 386/410)..
During the first 100 min after MVA injection, the SA curve of squalene increases to reach a peak and then declines exponentially thereafter (Fig. 1) . The area under the squalene curve and the maximum half-life of the decay exponential are calculated by input-output analysis (7) . The pool size of metabolically "active" squalene (8) where the "active" squalene pool (Msq) is defined as that portion of the total body squalene pool involved directly in cholesterol synthesis, and IT is the input (or synthesis) rate of squalene. As in the case of the tY, Msq also is a maximum estimate. To calculate these parameters by extrapolation of the logarithmically linear decay curve to time zero is theoretically unsound, we believe, since the squalene curve is obtained by formation from a precursor rather than by administration of squalene itself.
Ancillary procedures Diets were essentially squalene-free. This was assured by use of orally administered liquid formula feedings (9), calories being adjusted to maintain body weights constant (vitamins and minerals were given as supplements), and by solid foods diets that on analysis were shown to be exceedingly low in squalene.
Stools for sterol balance measurements were collected and analyzed as described elsewhere (1), using the internal standards chromic oxide (10) and fi-sitosterol (11) . Table 1 presents the relevant clinical information in seven patients studied to date, as well as kinetic data obtained by the labeled squalene technique. Since the major purpose of this report is to present the evidence validating the squalene kinetic method for computing cholesterol synthesis rates, the sterol balance data in six of the seven experiments are shown as benchmark determinations of cholesterol synthesis.
RESULTS
Three other patients also have been studied by this technique. Their data have not been included because of technical and metabolic faults. The eight studies reported in detail seem homogeneous to us by the following criteria: absence of changes in body weight and plasma levels of cholesterol during the test period, complete stool collections (judged by recoveries of the inert marker, chromic oxide), strict adherence to a low-squalene diet, and a smooth clinical course. Squalene kinetics A typical SA-time curve for plasma squalene after intravenous administration of [14C]MVA is shown in Fig. 1 . Plasma squalene and cholesterol became "4C-labeled within 1.5 min.
Medical Sciences: Liu et al. DISCUSSION The present method of describing the kinetics of plasma squalene is based on two premises: that the diet is low in squalene (so that total daily squalene input is wholly ascribable to synthesis) and that metabolically "active" squalene in tissues equilibrates rapidly with plasma squalene. Our experimental results appear to substantiate the latter assumption, but definitive proof of the equilibrium between plasma squalene and "active" squalene in tissues awaits the performance of experiments in animals. Since previous studies in other laboratories have furnished ample evidence that squalene is an obligatory precursor of cholesterol, it seems reasonable at this point to presume that the rate of squalene synthesis in man can be equated with that of cholesterol synthesis.
Comparisons of Squalene and Cholesterol Synthesis Rates. The correspondences between the data obtained by the squalene method and by the sterol balance method were reasonably good, although the data obtained by squalene kinetics were higher than the balance data, on average.
The squalene input data would be falsely high if labeled squalene were lost through the skin. However, repeated measurements of skin surface squalene have failed to show any significant excretion of radioactive squalene (<0.1% of the dose of squalene in three studies). Falsely high results also would be found if squalene were lost in urine or feces. However, repeated assays of squalene radioactivity in feces and urine have been negative (<0.1% of dose of squalene in two studies). An untested possibility is that a small amount of labeled squalene may be sequestered in one or another tissue and is released so slowly that we fail to detect its conversion to cholesterol. In Patient 1, isolated adipocytes obtained by needle aspiration were assayed at the peak of the labeled plasma squalene curve and also 2 hr later; although the mass of squalene was consistently large, no radioactivity above background was detected.
On the other hand, there is good reason to know that the balance method consistently underestimates cholesterol synthesis by 10-15%: urinary steroids derived from cholesterol normally total as much as 50 mg/day, and losses of plasma cholesterol through the skin also may occur (in six patients this loss averaged 35 + 8 mg/day, ref. 15 ). There also is a systematic loss of fecal neutral steroid sulfates: in 10 patients this averaged 26 mg/day but never exceeded 66 mg/day (6) . All of these outputs are neglected in the customary application of the sterol balance method.
The mean levels of cholesterol synthesis measured in six studies by balance and by squalene kinetics agreed within 8%, although the largest individual difference (Patient 7) was 30%. When comparisons were made of large numbers of cholesterol turnover rates obtained by sterol balance methods (1) and by kinetic studies of cholesterol itself (3) (44 such comparisons have been completed in this laboratory), the means agreed within 20%; however, in individual patients the discrepancies amounted to as much as 50%. Therefore, and in view of the several known sources of error in all these methods, we feel that the comparisons shown in Table 1 warrant the tentative conclusion that MVA-squalene kinetics can give a satisfactory estimate of daily cholesterol synthesis rates. Obviously, any statistical evaluation of the new and older methods awaits the acquisition of many more experimental comparisons.
Repetition of Test. Investigators may wish to obtain a second, third, etc., set of synthesis data on the same patient, either for the sake of testing reproducibility or to gauge the effect on synthesis of a change in regimen (new diet, drug, etc.). The present procedure permits this repetition as early as 6 weeks after the first test, provided that care is taken to make appropriate deductions of residual radioactivity in cholesterol from the results obtained during the second test. (16) , this possibility must also be explored in man.
Advantages and Future Applications. While the advantages of the present method have been enumerated in the final paragraph of the Abstract, the opportunity to measure cholesterol synthesis in the unsteady metabolic state seems to us its chief attraction. By contrast, currently accepted techniques (sterol balance and cholesterol kinetic studies) demand the steady state, which in turn imposes burdens on patients and on the laboratory that are avoided in the application of the squalene kinetic method.
We anticipate that the squalene kinetic method will help us to resolve a number of dilemmas for which no other solution is presently available-dilemmas created by our inability to distinguish cholesterol synthesis from cholesterol flux. For example, during neomycin administration there is a large increase in neutral steroid excretion in feces, yet it has not been possible to distinguish what part of this is due to increased cholesterol synthesis and what part to efflux of cholesterol from tissues (17) . Similar problems still exist in regard to the mode of action of clofibrate (18), #-sitosterol (19) , and other drugs, and to the effects of increased caloric intake or of isocaloric exchange of carbohydrate for fat calories (20) . In animal studies it may now be possible to dissect out the effects of body growth on cholesterol synthesis, since growth is characteristically an unsteady metabolic state (21) . We expect that the ability to carry out repeated measurements of cholesterol synthesis at relatively short intervals by the present method will allow us to clarify some of these uncertainties.
